XTX Topco’s Bristol-Myers Squibb BMY Stock Holding History

XTX Topco’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$382K	Sell	6,627 -2,312	-26%	-$133K	﹤0.01%	2704
2026 Q1	$542K	Buy	8,939 +5,077	+131%	+$296K	0.01%	1982
2025 Q4	$208K	Sell	3,862 -173,447	-98%	-$8.34M	0.01%	2370
2025 Q3	$8M	Buy	177,309 +154,076	+663%	+$7.2M	0.41%	7
2025 Q2	$1.08M	Buy	+23,233	New	+$1.14M	0.04%	620
2024 Q3	–	Sell	-91,465	Closed	-$3.8M	–	2110
2024 Q2	$3.8M	Buy	91,465 +73,183	+400%	+$3.27M	0.33%	22
2024 Q1	$991K	Buy	18,282 +11,602	+174%	+$591K	0.13%	163
2023 Q4	$343K	Buy	+6,680	New	+$351K	0.08%	518
2023 Q3	–	Sell	-13,929	Closed	-$891K	–	1578
2023 Q2	$891K	Buy	+13,929	New	+$934K	0.16%	119
2023 Q1	–	Sell	-23,730	Closed	-$1.71M	–	1286
2022 Q4	$1.71M	Buy	+23,730	New	+$1.79M	0.36%	17
2022 Q1	–	Sell	-4,856	Closed	-$303K	–	686
2021 Q4	$303K	Sell	4,856 -7,252	-60%	-$425K	0.17%	193
2021 Q3	$716K	Buy	12,108 +6,260	+107%	+$412K	0.24%	97
2021 Q2	$391K	Sell	5,848 -296	-5%	-$19.3K	0.13%	262
2021 Q1	$388K	Buy	+6,144	New	+$382K	0.19%	179

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

XTX Topco's BMY Position: Q2 2026 in Review

XTX Topco reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, selling an estimated $133K and leaving 6,627 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

XTX Topco first reported a position in BMY in Q1 2021 and has held it in 14 quarters since. The position peaked at $8M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

XTX Topco held 6,627 shares of Bristol-Myers Squibb worth $382K as of Q2 2026.
XTX Topco sold 2,312 Bristol-Myers Squibb shares in Q2 2026, an estimated $133K.
Bristol-Myers Squibb made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2704 holding.
XTX Topco first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 14 quarters since.
XTX Topco's Bristol-Myers Squibb position peaked at $8M in Q3 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.